Marrow vs Hims vs Ro: Honest Comparison of Men's Health Telehealth

If you're researching telehealth for GLP-1 medications, TRT, or ED treatment, you've probably landed on Hims, Roman (Ro), Marrow, or some combination. They all offer similar categories of treatment. The differences matter.

This is an honest comparison — we're Marrow, so take that context for what it's worth, but we'll represent the others fairly.

The Three Platforms

### Hims & Hers Founded: 2017 | Focus: Broad consumer health (hair, skin, sexual health, mental health, weight)

Hims is the 800-pound gorilla of men's telehealth. Massive brand recognition, polished marketing, wide treatment menu. They added weight loss (GLP-1) in 2023 and it became one of their fastest-growing categories.

Strengths: - Strong brand trust and name recognition - Well-polished product experience - Wide range of treatments under one roof - Established compounding pharmacy relationships

Limitations: - Pricing for GLP-1 is not the lowest in the market - General health platform, not specialized in metabolic/body composition - AI integration is relatively basic vs newer platforms - Customer service quality reviews are mixed at scale

GLP-1 pricing: Starts around $299/month for semaglutide; pricing has fluctuated based on supply and FDA compounding status

### Roman (Ro) Founded: 2017 | Focus: Men's health (ED, hair, testosterone, weight)

Roman pioneered the men's telehealth category for ED treatment and remains strong there. Their Rory platform addresses women's health. They've added weight loss relatively recently.

Strengths: - Deep expertise in ED and men's sexual health - Strong pharmacy infrastructure - Good telehealth experience for traditional consultations - Strong physician network

Limitations: - Weight loss / metabolic optimization feels bolted-on vs core - Less emphasis on body composition and optimization (more on disease treatment) - Pricing competitive but not the lowest - Platform somewhat dated compared to newer entrants

GLP-1 pricing: Competitive with Hims, typically $299-349/month starting

### Marrow Founded: 2026 | Focus: Body composition and metabolic optimization

Marrow is the newest of the three and built with a specific thesis: the next generation of health optimization platforms will be AI-first, not just telehealth-first. Physician oversight for prescriptions, AI for everything in between.

Strengths: - AI-powered intake (conversational vs static form) - AI health coaching built into the product — weekly check-ins, Q&A, progress tracking - Competitive pricing (semaglutide $249/month, tirzepatide $299/month) - Focus on body composition means treatment protocols are optimization-oriented, not just weight loss - Lab intelligence built-in (AI interprets labs in plain language, not just raw numbers)

Limitations: - Newer — less established brand trust - Smaller physician network vs scaled competitors - Still building breadth of treatment menu

GLP-1 pricing: Compounded semaglutide $249/month, tirzepatide $299/month

Head-to-Head: What Matters

### Price For GLP-1 medications — the highest-volume and highest-cost category — all three offer compounded options significantly below branded (Ozempic is $800-1,000+/month, Mounjaro is $1,000+/month).

Marrow's starting price is the lowest among the three for compounded GLP-1. This matters on an ongoing basis: the difference between $249 and $299 is $600/year; between $249 and $349 is $1,200/year.

### AI Integration This is where the platforms diverge most clearly going forward.

Hims and Ro were built as telehealth platforms with AI added. Marrow was built with AI as the primary patient interface. The practical difference: - Intake: Hims/Ro use structured forms. Marrow uses a conversational AI that adapts to your responses and generates a clinical summary. - Ongoing support: Hims/Ro offer messaging with care teams (physician-adjacent). Marrow's AI coach provides 24/7 contextual support with your treatment history, proactively checks in, and flags concerns to physicians when needed. - Lab review: Standard telehealth sends you lab PDFs. Marrow's lab intelligence interprets results in plain language, highlights trends, and generates physician recommendations.

### Treatment Philosophy Hims/Ro: Treat the presenting condition. You have ED → here's tadalafil. You want to lose weight → here's semaglutide.

Marrow: Optimize body composition and metabolic function. The distinction matters because the treatment protocol and coaching guidance differs when the goal is optimization vs symptom management.

### Physician Access All three platforms use licensed physicians for prescription decisions. Quality of physician oversight is similar. The difference is in what happens between physician touchpoints — where AI fills the gap vs human care teams.

Which Should You Choose?

Choose Hims if: - You want the most recognized brand name - You're interested in treatments beyond weight/TRT (mental health, skincare, etc.) - You're more comfortable with a well-established platform

Choose Roman if: - ED is your primary concern and you want specialists - You prefer Roman's platform experience - You want a men's health focus with strong heritage in sexual health

Choose Marrow if: - GLP-1 or TRT is your primary focus - AI coaching and proactive check-ins appeal to you - Cost matters (lowest price on compounded GLP-1) - You want body composition optimization, not just treatment of a condition - You're comfortable with a newer platform

The Bottom Line

All three will get you a prescription. The differences are: price, platform experience, AI integration, and treatment philosophy.

Marrow is built for what we think the next 5 years of telehealth look like — AI-coached, proactively managed, optimization-focused. We're biased, obviously. But the pricing is objectively competitive and the platform is built with genuine care.

[Start with Marrow](/start) — 24-hour physician review.